Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Clinical Efficacy and Safety of Erythroid Stimulating Agents in Sickle Cell Disease

Santosh Saraf, MD, Robert Molokie, MD, Michel Gowhari, DO, Johara Hassan, MD, Victor R. Gordeuk, MD

Blood (2012) 120 (21): 3218.

https://doi.org/10.1182/blood.V120.21.3218.3218

Published: 2012

Journal Articles

Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Annie L. Oh, MD, Pritesh R. Patel, MB, ChB, Santosh Saraf, MD, Karen Sweiss, PharmD, David Peace, MD, John G. Quigley, MD, Nadim Mahmud, MD, PhD, Steven Dudek, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 4474.

https://doi.org/10.1182/blood.V120.21.4474.4474

Published: 2012

Journal Articles

Role of Ethnicity in Clinical Outcomes of Patients with Ph-Negative Myeloproliferative Neoplasms

Santosh Saraf, MD, Ardaman Shergill, MD, Pritesh R. Patel, MB, ChB, John G. Quigley, MD, David Peace, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2012) 120 (21): 2076.

https://doi.org/10.1182/blood.V120.21.2076.2076

Published: 2012

Journal Articles

Early Detection of Renal Dysfunction in Pediatric Sickle Cell Patients

Marwah W. Farooqui, DO, Santosh Saraf, MD, Victor R. Gordeuk, MD, Kimberly Czech, MD, Eunice John, MD, Lewis L. Hsu, MD, PhD

Blood (2012) 120 (21): 1017.

https://doi.org/10.1182/blood.V120.21.1017.1017

Published: 2012

Journal Articles

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Dolores Mahmud, PhD, Simona Taioli, MS, Santosh Saraf, MD, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 4016.

https://doi.org/10.1182/blood.V118.21.4016.4016

Published: 2011

Journal Articles

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Santosh Saraf, MD, Hiroto Araki, MD, PhD, Benjamin Petro, BS, Kazumi G Yoshinaga, MS, Simona Taioli, MS, Amer Sidani, MD, John G. Quigley, MD, Damiano Rondelli, MD, Nadim Mahmud, MD, PhD

Blood (2011) 118 (21): 1920.

https://doi.org/10.1182/blood.V118.21.1920.1920

Published: 2011

Journal Articles

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Santosh Saraf, MD, Pritesh R. Patel, MB, ChB, Howard Ozer, MD, PhD, David Peace, MD, Sangeetha Nimmagadda, MD, John G. Quigley, MD, Damiano Rondelli, MD

Blood (2011) 118 (21): 4213.

https://doi.org/10.1182/blood.V118.21.4213.4213

Published: 2011

Journal Articles

Fever In Hospitalized Adult Patients with Sickle Cell Disease

Deepa Jeyakumar, MD, Matthew Zibelman, MD, Ryan Hurth, MD, Lani Krauz, RN, Santosh Saraf, MD, Robert Molokie, MD, Joseph DeSimone, PhD

Blood (2010) 116 (21): 2652.

https://doi.org/10.1182/blood.V116.21.2652.2652

Published: 2010

Journal Articles

Usual Clinical Parameters Underestimate the Incidence and Significance of Erythropoietin Deficiency as a Risk Factor for Death in Sickle Cell Disease.

Santosh Saraf, Seema Sidhwani, Mohammed Farooqui, Stephen Vara, Joseph DeSimone, Robert Molokie, Yogenthiran Saunthararajah

Blood (2007) 110 (11): 3791.

https://doi.org/10.1182/blood.V110.11.3791.3791

Published: 2007

Journal Articles

Decitabine Improves Clinical Outcomes in Severely Ill Sickle Cell Disease Patients Who Have Exhausted Standard of Care Options.

Yogenthiran Saunthararajah, MD, Robert Molokie, MD, Seema Sidhwani, MD, Santosh Saraf, MD, Stephen Vara, MD, Michel Gowhari, MD, Joseph DeSimone, PhD

Blood (2007) 110 (11): 3792.

https://doi.org/10.1182/blood.V110.11.3792.3792

Published: 2007

Journal Articles

African American Patients with Multiple Myeloma Have Prolonged Responses after Autologous Stem Cell Transplantation.

Santosh Saraf, MD, Yi-Hsiang Chen, MD, PhD, Lisa C. Dobogai, NP, Yogen Saunthararajah, MD, David Peace, MD, Ronald Hoffman, MD, Nadim Mahmud, MD, PhD, Sandeep Chunduri, MD, Damiano Rondelli, MD

Blood (2005) 106 (11): 3131.

https://doi.org/10.1182/blood.V106.11.3131.3131

Published: 2005

NARROW

Clinical Efficacy and Safety of Erythroid Stimulating Agents in Sickle Cell Disease

Decreased Pulmonary Function in Asymptomatic Long Term Survivors After Busulfan-Based Myeloablative Allogeneic Hematopoietic Stem Cell Transplant

Role of Ethnicity in Clinical Outcomes of Patients with Ph-Negative Myeloproliferative Neoplasms

Early Detection of Renal Dysfunction in Pediatric Sickle Cell Patients

Possible Reduced Immunogenicity of Chromatin Modifying Agents Expanded Cord Blood Grafts Is Likely Due to STAT3 Inhibition,

Ex Vivo Expansion of Human Mobilized Peripheral Blood Stem Cells Using Epigenetic Modifiers

Favorable Responses to Novel Agents for Multiple Myeloma in African American Patients,

Fever In Hospitalized Adult Patients with Sickle Cell Disease

Usual Clinical Parameters Underestimate the Incidence and Significance of Erythropoietin Deficiency as a Risk Factor for Death in Sickle Cell Disease.

Decitabine Improves Clinical Outcomes in Severely Ill Sickle Cell Disease Patients Who Have Exhausted Standard of Care Options.

African American Patients with Multiple Myeloma Have Prolonged Responses after Autologous Stem Cell Transplantation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only